This was the stock's third consecutive day of gains.

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of ...

We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look ...

Outdated BIOS firmware in Illumina iSeq 100 allows attackers to disable devices or install malware, threatening critical ...

Illumina Inc. closed $20.65 below its 52-week high ($156.66), which the company achieved on November 5th.

Illumina's ILMN +0.16% Get Free Report short percent of float has fallen 9.53% since its last report. The company recently ...

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through ...

(Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year 2024. The financial results for YTD 2024 and Q3 2023 and YTD 2023 include ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing MiSeq™ i100 Series, its simplest and fastest benchtop sequencer for ...

The firm owned 3,137 shares of the life sciences company’s stock after selling 360 shares during the period. Quest Partners LLC’s holdings in Illumina were worth $409,000 as of its most recent ...